A detailed history of Wells Fargo & Company transactions in Immunic, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 447 shares of IMUX stock, worth $527. This represents 0.0% of its overall portfolio holdings.

Number of Shares
447
Previous 978 54.29%
Holding current value
$527
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.98 - $1.44 $520 - $764
-531 Reduced 54.29%
447 $0
Q1 2024

May 10, 2024

BUY
$1.14 - $1.53 $441 - $592
387 Added 65.48%
978 $1,000
Q4 2023

Feb 09, 2024

BUY
$0.97 - $1.6 $16 - $27
17 Added 2.96%
591 $0
Q3 2023

Nov 13, 2023

BUY
$1.35 - $2.87 $87 - $186
65 Added 12.77%
574 $0
Q2 2023

Aug 15, 2023

BUY
$1.33 - $2.51 $14 - $27
11 Added 2.21%
509 $1,000
Q1 2023

May 12, 2023

BUY
$1.35 - $2.87 $41 - $88
31 Added 6.64%
498 $0
Q4 2022

Feb 13, 2023

BUY
$1.13 - $10.8 $59 - $572
53 Added 12.8%
467 $0
Q3 2022

Nov 14, 2022

SELL
$3.0 - $5.49 $159 - $290
-53 Reduced 11.35%
414 $2,000
Q2 2022

Aug 12, 2022

SELL
$3.13 - $12.25 $3,292 - $12,887
-1,052 Reduced 69.26%
467 $2,000
Q1 2022

May 16, 2022

SELL
$9.54 - $14.26 $64,442 - $96,326
-6,755 Reduced 81.64%
1,519 $17,000
Q4 2021

Feb 14, 2022

BUY
$7.34 - $10.25 $58,837 - $82,164
8,016 Added 3106.98%
8,274 $79,000
Q3 2021

Nov 15, 2021

SELL
$8.05 - $13.29 $209 - $345
-26 Reduced 9.15%
258 $2,000
Q2 2021

Aug 16, 2021

SELL
$11.76 - $16.85 $4,633 - $6,638
-394 Reduced 58.11%
284 $3,000
Q1 2021

May 13, 2021

SELL
$14.21 - $25.3 $357,665 - $636,801
-25,170 Reduced 97.38%
678 $10,000
Q4 2020

Feb 09, 2021

BUY
$14.8 - $20.37 $87,394 - $120,284
5,905 Added 29.61%
25,848 $395,000
Q3 2020

Nov 05, 2020

BUY
$11.74 - $22.0 $24,313 - $45,562
2,071 Added 11.59%
19,943 $371,000
Q2 2020

Aug 13, 2020

BUY
$5.67 - $15.86 $40,018 - $111,939
7,058 Added 65.27%
17,872 $216,000
Q1 2020

May 14, 2020

BUY
$4.22 - $9.8 $45,635 - $105,977
10,814 New
10,814 $65,000

Others Institutions Holding IMUX

About IMMUNIC, INC.


  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $36.1M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.